93 7219 Pill: yellow, capsule/oblong, 14mm
The pill with imprint 93 7219 (Yellow, Capsule/Oblong, 14mm) has been identified as Topiramate 100 mg and is used for Lennox-Gastaut Syndrome, Migraine Prevention, Epilepsy, Seizure Prevention, and Seizures. It belongs to the drug class carbonic anhydrase inhibitor anticonvulsants and is not a controlled substance.
Images for 93 7219
Topiramate
- Imprint
- 93 7219
- Strength
- 100 mg
- Color
- Yellow
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- Inactive Ingredients
-
silicon dioxide,
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol 4000,
corn starch,
sodium starch glycolate type A potato,
titanium dioxide,
hypromellose 2910 (15 mPa.s),
polydextrose,
ferric oxide yellow,
ferrosoferric oxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00093-7219 (Discontinued) | Teva Pharmaceuticals USA, Inc. |
| 68071-0813 | Nucare Pharmaceuticals Inc. (repackager) |
Related images for "93 7219"
Featured
Semaglutide
Semaglutide is a GLP-1 agonist used for weight loss, type 2 diabetes, and reducing cardiovascular ...
Reviews & ratings
More about topiramate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,343)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- Breastfeeding
Patient resources
Other brands
Topamax, Trokendi XR, Eprontia, Qudexy XR, Topiragen
Professional resources
- Topiramate monograph
- Topiramate (FDA)
- Topiramate Capsules (FDA)
- Topiramate ER Capsules (FDA)
- Topiramate Oral Solution (FDA)
- Topiramate Tablets (FDA)
Other brands
Topamax, Trokendi XR, Eprontia, Qudexy XR
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.